由于公司报告的财务结果好坏参半,Insmed执行官出售了大量股票。 Insmed executives sell significant stock as company reports mixed financial results.

Insmed Incorporated 内部人士 Martina M.D. Insmed Incorporated insiders Martina M.D. Flammer和CEO William Lewis最近出售了他们公司大部分股票。 Flammer and CEO William Lewis have recently sold significant portions of their company stock. Flammer在两天内总共出售了9 516股股票,使她的所有权减少了5.73%。 Flammer sold a total of 9,516 shares over two days, reducing her ownership by 5.73%. Lewis出售了2 978股,将持有股份减少了0.75%。 Lewis sold 2,978 shares, decreasing his holding by 0.75%. 同时,Insmed的股票价格起伏不定,最近中午的交易价值为65.25美元。 Meanwhile, Insmed's stock price has fluctuated, with a recent midday trading value of $65.25. 该公司报告说,Q3收入增加了18.1%,达到9 340万美元,但每股估计收入没有增加。 The company reported a 18.1% increase in Q3 revenue to $93.40 million but missed earnings per share estimates. Insmed的股票有一个中速购买共识,目标价格为83.67美元。 Insmed's stock has a Moderate Buy consensus with a target price of $83.67.